Saudi Arabia Bans Syringe Cosmetics From 2027

Lucas Bennett 08/12/2026

Saudi Arabia is ushering in a significant overhaul of cosmetic product presentation, setting new standards for how beauty products are packaged, labeled, and marketed. The Saudi Food and Drug Authority (SFDA) is implementing stringent new requirements, particularly targeting concentrated treatments sold in pharmaceutical-inspired formats, effective January 1, 2027.

This regulatory shift addresses safety concerns and prevents consumer confusion. Under the new rules, cosmetics intended for external use will no longer be permitted in syringe-style packaging. This measure is designed to eliminate the risk of these products being mistaken for injectable pharmaceuticals, emphasizing product distinction and consumer safety above all else.

While the syringe format is off the table for external cosmetics, other delivery methods remain viable. Cosmetics packaged in ampoules and vials are permitted to stay on the market, provided they adhere to strict labeling mandates. These containers must carry clear warnings, in both Arabic and English, explicitly stating that the products are for external cosmetic use only and must not be injected.

Further guidelines instruct manufacturers to include important safety precautions on their labels, warning consumers to avoid direct eye contact and exercise care when opening the products. Marketing materials are also strictly prohibited from suggesting that cosmetics can be administered through injection or any other device that penetrates the skin, reinforcing the boundary between cosmetic and pharmaceutical use.

This directive places a crucial compliance timeline on the beauty sector in the Kingdom. Manufacturers, brands, and importers operating in Saudi Arabia—especially those dealing with serums and highly concentrated treatments—now have until December 31, 2026, to ensure their packaging, labeling, and marketing materials meet these new standards.

The move signals a commitment to transparency and rigorous quality control within the beauty industry. Companies looking to maintain market access and build consumer trust will need to proactively review their product lines well ahead of the 2027 deadline, ensuring that innovation goes hand-in-hand with responsible presentation.